Biopharmaceuticals Market Scope And Analysis

  • Report Code : TIPRE00029847
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 346
Buy Now

Biopharmaceuticals Market Size and Scope by 2031

Buy Now


Biopharmaceuticals Market Report Scope

Report Attribute Details
Market size in 2022 US$ 329.97 Billion
Market Size by 2028 US$ 700.87 Billion
Global CAGR (2022 - 2028) 13.4%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By Product Type
  • Monoclonal Antibodies
  • Recombinant Vaccines
  • Conventional Vaccines
  • Recombinant Growth Factors
  • Purified Proteins
  • Recombinant Proteins
  • Recombinant Hormones
  • Recombinant Enzymes
  • Cell & Gene Therapies
  • Cytokines/Interferon/Interleukins
By Application
  • Oncology
  • Inflammatory & Infectious Disease
  • Autoimmune Disorders
  • Metabolic Disorders
  • Hormonal Disorders & Growth Failure
  • Cardiovascular Diseases
  • Neurological Diseases
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Amgen Inc
  • AbbVie Inc
  • Eli Lilly and Co
  • Bristol Myers Squibb Co
  • Johnson Johnson
  • Thermo Fisher Scientific Inc
  • AGC Biologics AS
  • Lonza Group AG
  • WuXi Biologics Inc